LIGAND PHARMACEUTICALS INCORPORATED (LGND) Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3

LIGAND PHARMACEUTICALS INCORPORATED Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3

LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 of $651.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2014-12-01.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 · last filed 2014-12-12

• LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for fiscal 2014 was $651.00K, a 0.00% change from fiscal 2013.
• LIGAND PHARMACEUTICALS INCORPORATED fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for fiscal 2013 was $651.00K.